Early oxidative stress in amniotic fluid of pregnancies with Down syndrome

被引:68
作者
Perrone, S. [1 ]
Longini, M. [1 ]
Bellieni, C. V. [1 ]
Centini, G. [1 ]
Kenanidis, A. [1 ]
De Marco, L. [1 ]
Petraglia, F. [1 ]
Buonocore, G. [1 ]
机构
[1] Univ Siena, Dept Pediat Obstet & Reprod Med, Policlin Le Scotte, I-53100 Siena, Italy
关键词
Down syndrome; free radicals; fetal growth restriction; isoprostanes; superoxide dismutase; oxidative stress; lipid peroxidation;
D O I
10.1016/j.clinbiochem.2006.10.019
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objective: Some evidence suggests that oxidative stress, due to an imbalance between oxidants and antioxidants, occurs in babies with Down syndrome (DS). This study tests the hypothesis that oxidative stress occurs early in DS pregnancies. Design and methods: Isoprostanes (IPs), a new marker of free radical-catalyzed lipid peroxidation, were measured in amniotic fluid from pregnancies with normal, growth restricted and DS fetuses, diagnosed by karyotype analysis of amniotic cells cultured. Results: A nine-fold increase in IP concentrations was found in amniotic fluid of pregnancies with DS fetuses. This increase (595.15; 542.96-631.64 pg/ml, median; 95% CI), was greater than in pregnancies with fetal growth-restricted fetuses (155; 130.57-172.23 pg/ml, median; 95% CI) and normal fetuses (67; 49.82-98.38 pg/ml, median; 95% Cl; p < 0.0001). Conclusions: The study reveals that oxidative stress occurs early in pregnancy and supports the idea of testing whether prenatal antioxidant therapy may prevent or delay the onset of oxidative stress diseases in the DS population. (c) 2006 The Canadian Society of Clinical Chemists. All rights reserved.
引用
收藏
页码:177 / 180
页数:4
相关论文
共 33 条
[1]   IMMUNOREACTIVE SOD-1 IN AMNIOTIC-FLUID, AMNIOTIC CELLS AND FIBROBLASTS FROM TRISOMY 21 FETUS [J].
BAETEMAN, MA ;
MATTEI, MG ;
BARET, A ;
GAMERRE, M ;
MATTEI, JF .
ACTA PAEDIATRICA SCANDINAVICA, 1985, 74 (05) :697-700
[2]   Radioimmunoassay of 8-iso-prostaglandin F2α:: an index for oxidative injury via free radical catalysed lipid peroxidation [J].
Basu, S .
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 1998, 58 (04) :319-325
[3]   Fetal growth velocity: Kinetic, clinical, and biological aspects [J].
Bertino, E ;
DiBattista, E ;
Bossi, A ;
Pagliano, M ;
Fabris, C ;
Aicardi, G ;
Milani, S .
ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 1996, 74 (01) :F10-F15
[4]   Sources of reactive oxygen species production in excitotoxin-stimulated cerebellar granule cells [J].
Boldyrev, AA ;
Carpenter, DO ;
Huentelman, MJ ;
Peters, CM ;
Johnson, P .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 256 (02) :320-324
[5]   SUPEROXIDE-DISMUTASE, GLUTATHIONE-PEROXIDASE AND LIPOPEROXIDATION IN DOWNS-SYNDROME FETAL BRAIN [J].
BROOKSBANK, BWL ;
BALAZS, R .
DEVELOPMENTAL BRAIN RESEARCH, 1984, 16 (01) :37-44
[6]  
Davì G, 1999, CIRCULATION, V99, P224
[7]  
de Haan J B, 1997, Adv Pharmacol, V38, P379
[8]  
DEHAAN JB, 1995, BIOCHEM MOL BIOL INT, V35, P1281
[9]   Role of redox in fetal development and neonatal diseases [J].
Dennery, PA .
ANTIOXIDANTS & REDOX SIGNALING, 2004, 6 (01) :147-153
[10]   SUPEROXIDE DISMUTASES [J].
FRIDOVICH, I .
ANNUAL REVIEW OF BIOCHEMISTRY, 1975, 44 :147-159